Mesoblast's high-risk programs drive inflated valuation. Find out why MESO stock remains a "sell" as execution risks outweigh ...

Discover effective supplements for migraine prevention and learn who should or shouldn't use them. Explore evidence-based ...

The most common cause of chronic pain in dogs is arthritis (1), and although they may be stiff and reluctant to walk, the ...

There is good news for those with acute pain, as the FDA has approved a first-of-its-kind pain medication, and it’s one ...

Journavx can be taken with ibuprofen for its anti-inflammatory effects. The prescription medication is not in pharmacies yet, but it maybe there by the end of February. Click here to report a typo.

Acupuncture is proving effective for chronic sciatica relief A new clinical trial reveals its potential to reduce pain and ...

In a turbulent market environment, SCLX stock has reached a 52-week low, trading at $0.33, with a market capitalization of $62.12 million. This price level reflects a significant downturn for the ...

Acute and chronic postoperative pain and functional disability persisted among patients who underwent posterior spinal fusion despite multimodal analgesic management.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

When prescribing opioids for acute pain, physicians should be attentive to a patient’s individual risk factors, according to ...